Staff report

Kimberly-Clark Corp. and Kenvue Inc. announced that the shareholders of both boards voted Thursday to approve Kimberly-Clark’s acquisition of the consumer health company.

Based on preliminary voting results, approximately 96% of the shares present at Kimberly-Clark’s special meeting were voted to approve the issuance of shares of Kimberly-Clark common stock in connection with the transaction. Approximately 99% of shares voted at Kenvue’s special meeting voted to adopt the merger agreement, representing approximately 77% of all outstanding shares.

“This is an exciting milestone and advances our efforts to create a preeminent global health and wellness leader that will raise the standard of care for billions of people around the world and generate significant value for shareholders,” said Mike Hsu, Kimberly-Clark chairman and CEO.

Final vote results are subject to certification by the companies’ respective independent inspectors of elections and will be filed with the U.S. Securities and Exchange Commission.

The transaction is expected to close in the second half of 2026.

Kimberly-Clark’s brands include Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, and Depend.

Kenvue is a consumer health company whose products include Aveeno, Band-Aid, Johnson’s, Listerine, Neutrogena and Tylenol.